Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 153,000 | 133,000 | 199,000 | 215,000 | 238,000 |
| Cost of Goods | 23,000 | 42,000 | 34,000 | 27,000 | 37,000 |
| Gross Profit | 130,000 | 91,000 | 165,000 | 188,000 | 201,000 |
| Operating Expenses | 319,000 | 133,000 | 108,000 | 100,000 | 126,000 |
| Operating Income | -189,000 | -42,000 | 57,000 | 88,000 | 75,000 |
| Interest Expense | 6,000 | 5,000 | 7,000 | 5,000 | 5,000 |
| Other Income | 4,000 | 5,000 | 6,000 | 6,000 | 7,000 |
| Pre-tax Income | -191,000 | -42,000 | 56,000 | 89,000 | 77,000 |
| Income Tax | -28,000 | 13,000 | 8,000 | 14,000 | 11,000 |
| Net Income Continuous | -163,000 | -55,000 | 48,000 | 75,000 | 66,000 |
| Net Income | $-163,000 | $-55,000 | $48,000 | $75,000 | $66,000 |
| EPS Basic Total Ops | -1.10 | -0.40 | 0.35 | 0.50 | 0.45 |
| EPS Basic Continuous Ops | -1.11 | -0.38 | 0.35 | 0.50 | 0.45 |
| EPS Diluted Total Ops | -1.10 | -0.35 | 0.30 | 0.50 | 0.45 |
| EPS Diluted Continuous Ops | -1.05 | -0.35 | 0.30 | 0.50 | 0.44 |
| EBITDA(a) | $-180,000 | $-34,000 | $64,000 | $94,000 | $82,000 |